orthostatic hypotension

临床试验

计划入组 80 人 · 首次发布于 2022 年 3 月 25 日

已完成

NCT02123303

Orthostatic Hypotension Among Veterans

计划入组 300 人 · 首次发布于 2014 年 4 月 25 日

Unknown

NCT03732716

Sarcopenia and Orthostatic Hypotension

计划入组 100 人 · 首次发布于 2018 年 11 月 7 日

药物

查看全部 32 →

Small Molecule

Approved

Midodrine(Proamatine)

生产企业：Apotex inc etobicoke site, Impax pharmaceuticals，另有 4 家

相关疾病：Symptomatic Orthostatic Hypotension

C₁₂H₁₈N₂O₄ · Rx

Small Molecule

Approved

Droxidopa(Northera)

相关疾病：Symptomatic Neurogenic Orthostatic Hypotension (NOH)

C₉H₁₁NO₅ · Rx

Small Molecule

Approved

Methoxamine

生产企业：Glaxosmithkline

C₁₁H₁₇NO₃ · Rx

机构

Kidney & Hypertension Center

United States

Shanghai Institute of Hypertension

China

资讯

查看全部 322 →

11个月前

CuraSen Therapeutics Initiates Phase IIa Trial for Neurogenic Orthostatic Hypotension Treatment

去年

Ampreloxetine Shows Promise for Neurogenic Orthostatic Hypotension in MSA Patients Without Worsening Supine Hypertension

去年

临床试验

Hypercapnia in Orthostatic Hypotension

Orthostatic Hypotension Among Veterans

Sarcopenia and Orthostatic Hypotension

药物

Midodrine(Proamatine)

Droxidopa(Northera)

Methoxamine

机构

Kidney & Hypertension Center

Shanghai Institute of Hypertension

资讯

CuraSen Therapeutics Initiates Phase IIa Trial for Neurogenic Orthostatic Hypotension Treatment

Ampreloxetine Shows Promise for Neurogenic Orthostatic Hypotension in MSA Patients Without Worsening Supine Hypertension

CuraSen Launches Phase 1 Trial of CuraAX for Neurogenic Orthostatic Hypotension and Cognitive Impairment